Characterization of CYP2C19 and CYP2C9 from Human Liver: Respective Roles in Microsomal Tolbutamide, S-Mephenytoin, and Omeprazole Hydroxylations

Author： Lasker J.M. Wester M.R. Aramsombatdee E. Raucy J.L.

Publisher： Elsevier

ISSN： 0003-9861

Source： Archives of Biochemistry and Biophysics, Vol.353, Iss.1, 1998-05, pp. : 16-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of CYP2C9 as a Human Liver Microsomal Linoleic Acid Epoxygenase

By Draper A.J. Hammock B.D.

Archives of Biochemistry and Biophysics, Vol. 376, Iss. 1, 2000-04 ,pp. : 199-205

Elsevier

Access to resources Recommend Favorite

Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily

By Lewis D. F. V. Dickins M. Weaver R. J. Eddershaw P. J. Goldfarb P. S. Tarbit M. H.

Xenobiotica, Vol. 28, Iss. 3, 1998-03 ,pp. : 235-268

Informa Healthcare

Access to resources Recommend Favorite

Rosuvastatin suppresses the liver microsomal CYP2C11 and CYP2C6 expression in male Wistar rats

By Zachařová Alice Šiller Michal Špičáková Alena Anzenbacherová Eva Škottová Nina Anzenbacher Pavel Večeřa Rostislav

Xenobiotica, Vol. 42, Iss. 8, 2012-08 ,pp. : 731-736

Informa Healthcare

Access to resources Recommend Favorite

Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4

By Coller J. K. Somogyi A. A. Bochner F.

Xenobiotica, Vol. 29, Iss. 10, 1999-10 ,pp. : 973-986

Informa Healthcare

Access to resources Recommend Favorite

Lipophilicity Relationships in Inhibitors of CYP2C9 and CYP2C19 Enzymes

By Lewis David F.V. Lake Brian G. Ito Yuko Dickins Maurice

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 21, Iss. 4, 2006-08 ,pp. : 385-389

Informa Healthcare

Access to resources Recommend Favorite